US Rule Set to Sharply Raise Cost of Canadian Drug Imports for Americans

A new US rule is set to sharply raise the cost of Canadian prescription drugs for millions of Americans, representing a policy reversal on pharmaceutical imports. The change marks a significant shift from prior administration positions that had encouraged lower-cost drug imports from Canada as a way to reduce healthcare costs for American consumers.